Sodium Sulfamethoxazole/Aminocaproic Acid/Glycyrrhizinate dipotassium/Chlorphenamine Maleate

磺胺甲恶唑钠/氨基己酸/甘草酸二钾/马来酸氯苯那敏

Report date: 2023/08/11 09:18:39
NME

Base Information

Drug NameSodium Sulfamethoxazole/Aminocaproic Acid/Glycyrrhizinate dipotassium/Chlorphenamine Maleate
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionDihydropteroate synthase inhibitorsPlasminogen activators inhibitorsCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors +[4] 
TargetsDihydropteroate synthasePlasminogen activatorsCorticosteroid 11-beta-dehydrogenase isozyme 1 +[4] 
Therapy Area/IndicationsBlepharitisChalazionConjunctivitis, Bacterial
Global Approved IndicationsBlepharitisChalazionConjunctivitis, Bacterial
Approved Indications in ChinaBlepharitisChalazionConjunctivitis, Bacterial
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsYes Aminocaproic AcidGlycyrrhizinate dipotassiumChlorphenamine Maleate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMentholatum (China) Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsBlepharitisChalazionConjunctivitis, Bacterial
Inactive IndicationsN/A

Other Information

ATC CodeS01B
Related LinksN/A